Published in Proc Natl Acad Sci U S A on January 16, 2001
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol (2002) 2.50
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39
Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol (2004) 1.98
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol (2005) 1.90
The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology (2006) 1.86
Orthobunyaviruses: recent genetic and structural insights. Nat Rev Microbiol (2014) 1.81
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol (2005) 1.69
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol (2003) 1.67
The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol (2006) 1.66
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology (2005) 1.63
RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology (2008) 1.61
Genomic characterisation of three Mapputta group viruses, a serogroup of Australian and Papua New Guinean bunyaviruses associated with human disease. PLoS One (2015) 1.47
Virus replication in engineered human cells that do not respond to interferons. J Virol (2003) 1.44
Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J Virol (2003) 1.42
Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog (2013) 1.42
In memoriam--Richard M. Elliott (1954-2015). J Gen Virol (2015) 1.39
Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol (2006) 1.36
Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol (2007) 1.35
Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell (2003) 1.32
La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J Virol (2005) 1.31
Bunyamwera bunyavirus RNA synthesis requires cooperation of 3'- and 5'-terminal sequences. J Virol (2004) 1.30
Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J Virol (2003) 1.28
Negative-strand tospoviruses and tenuiviruses carry a gene for a suppressor of gene silencing at analogous genomic positions. J Virol (2003) 1.26
Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J Virol (2006) 1.26
Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe. Vet Res (2013) 1.20
Mutational analysis of the Bunyamwera orthobunyavirus nucleocapsid protein gene. J Virol (2009) 1.19
Bunyamwera orthobunyavirus S-segment untranslated regions mediate poly(A) tail-independent translation. J Virol (2009) 1.18
Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol (2012) 1.17
Discovery of a unique novel clade of mosquito-associated bunyaviruses. J Virol (2013) 1.17
Bovine epizootic encephalomyelitis caused by Akabane virus in southern Japan. BMC Vet Res (2008) 1.16
Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res (2009) 1.16
A bunyamwera virus minireplicon system in mosquito cells. J Virol (2004) 1.16
Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J Virol (2003) 1.13
Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus. Epidemics (2012) 1.10
Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol (2014) 1.10
Viruses in the Anopheles A, Anopheles B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not encode an NSs protein. J Virol (2009) 1.09
Mutational analyses of the nonconserved sequences in the Bunyamwera Orthobunyavirus S segment untranslated regions. J Virol (2005) 1.07
Key Golgi factors for structural and functional maturation of bunyamwera virus. J Virol (2005) 1.06
Genetic characterization of the Wyeomyia group of orthobunyaviruses and their phylogenetic relationships. J Gen Virol (2012) 1.05
Role of N-linked glycans on bunyamwera virus glycoproteins in intracellular trafficking, protein folding, and virus infectivity. J Virol (2005) 1.02
Evolutionary and phenotypic analysis of live virus isolates suggests arthropod origin of a pathogenic RNA virus family. Proc Natl Acad Sci U S A (2015) 1.01
The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. J Gen Virol (2010) 1.01
The Andes hantavirus NSs protein is expressed from the viral small mRNA by a leaky scanning mechanism. J Virol (2011) 0.98
Molecular biology of rift valley Fever virus. Open Virol J (2010) 0.98
Attenuation of bunyamwera orthobunyavirus replication by targeted mutagenesis of genomic untranslated regions and creation of viable viruses with minimal genome segments. J Virol (2012) 0.97
Viperin, MTAP44, and protein kinase R contribute to the interferon-induced inhibition of Bunyamwera Orthobunyavirus replication. J Virol (2012) 0.97
Bunyaviruses and the type I interferon system. Viruses (2009) 0.96
Role of Bunyamwera Orthobunyavirus NSs protein in infection of mosquito cells. PLoS Negl Trop Dis (2012) 0.94
Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys. Virol J (2011) 0.92
Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes. Virol J (2007) 0.92
A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells. J Virol (2008) 0.92
The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One (2010) 0.92
Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases. J Virol (2013) 0.89
NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery. J Gen Virol (2014) 0.88
The transient nature of Bunyamwera orthobunyavirus NSs protein expression: effects of increased stability of NSs protein on virus replication. PLoS One (2013) 0.86
The NSs protein of tomato spotted wilt virus is required for persistent infection and transmission by Frankliniella occidentalis. J Virol (2014) 0.86
Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses (2013) 0.85
Analysis of the Tomato spotted wilt virus ambisense S RNA-encoded hairpin structure in translation. PLoS One (2012) 0.85
Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge. J Virol (2014) 0.85
Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist. J Virol (2015) 0.85
Inhibitors of the interferon response enhance virus replication in vitro. PLoS One (2014) 0.84
Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol (2013) 0.83
Arenavirus reverse genetics for vaccine development. J Gen Virol (2013) 0.83
Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection. Immunity (2016) 0.83
Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells. J Virol (2015) 0.82
Flexibility of bunyavirus genomes: creation of an orthobunyavirus with an ambisense S segment. J Virol (2015) 0.82
An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein. MBio (2014) 0.81
The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis. J Biol Chem (2015) 0.81
Evolution of the Bunyamwera virus polymerase to accommodate deletions within genomic untranslated region sequences. J Virol (2015) 0.80
Transcriptome analysis reveals the host response to Schmallenberg virus in bovine cells and antagonistic effects of the NSs protein. BMC Genomics (2015) 0.80
Molecular characterization of Chittoor (Batai) virus isolates from India. Indian J Med Res (2012) 0.79
Generation of Recombinant Oropouche Viruses Lacking the Nonstructural Protein NSm or NSs. J Virol (2015) 0.78
Extracellular Vesicles Mediate Receptor-Independent Transmission of Novel Tick-Borne Bunyavirus. J Virol (2015) 0.78
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virol J (2016) 0.78
No Evidence of Gouléako and Herbert Virus Infections in Pigs, Côte d'Ivoire and Ghana. Emerg Infect Dis (2015) 0.77
The Antiviral RNAi Response in Vector and Non-vector Cells against Orthobunyaviruses. PLoS Negl Trop Dis (2017) 0.77
Mosquito-borne viruses and suppressors of invertebrate antiviral RNA silencing. Viruses (2014) 0.77
Modulation of Potassium Channels Inhibits Bunyavirus Infection. J Biol Chem (2015) 0.75
Antibodies to the core proteins of Nairobi sheep disease virus/Ganjam virus reveal details of the distribution of the proteins in infected cells and tissues. PLoS One (2015) 0.75
Analysis of Arbovirus Isolates from Australia Identifies Novel Bunyaviruses Including a Mapputta Group Virus from Western Australia That Links Gan Gan and Maprik Viruses. PLoS One (2016) 0.75
The nonstructural protein NSs of Schmallenberg virus is targeted to the nucleolus and induces nucleolar disorganization. J Virol (2016) 0.75
Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses. J Virol (2017) 0.75
Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins. mSphere (2017) 0.75
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol (2000) 7.00
A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques (1991) 4.99
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci U S A (1996) 3.80
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol (1999) 2.99
Molecular biology of the Bunyaviridae. J Gen Virol (1990) 2.84
La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. J Virol (1984) 2.80
An influenza virus containing nine different RNA segments. Virology (1991) 2.66
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev (1994) 2.64
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51
The beta-interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem (1994) 2.36
Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins. Virology (1995) 2.13
Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol (1994) 2.05
Emerging viruses: the Bunyaviridae. Mol Med (1997) 1.87
The S RNA genome segments of Batai, Cache Valley, Guaroa, Kairi, Lumbo, Main Drain and Northway bunyaviruses: sequence determination and analysis. J Gen Virol (1994) 1.84
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
Synthesis of bunyavirus-specific proteins in a continuous cell line (XTC-2) derived from Xenopus laevis. J Gen Virol (1985) 1.68
Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology (1993) 1.50
Studies on lumbo virus replication. I. RNA-dependent RNA polymerase associated with virions. Virology (1976) 1.46
Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest (1984) 1.44
Translational requirement of La Crosse virus S-mRNA synthesis: in vitro studies. J Virol (1987) 1.43
Attenuation of virulence of a bunyavirus involving an L RNA defect and isolation of LAC/SSH/LAC and LAC/SSH/SSH reassortants. Virology (1981) 1.39
Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs. J Virol (1992) 1.36
Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism. J Virol (1987) 1.34
Non-random reassortment between the tripartite RNA genomes of La Crosse and snowshoe hare viruses. J Gen Virol (1992) 1.32
Persistent infection of Aedes albopictus C6/36 cells by Bunyamwera virus. Virology (1986) 1.10
Genetic interactions among viruses of the Bunyamwera complex. J Virol (1981) 1.07
La Crosse virus infection of mammalian cells induces mRNA instability. J Virol (1988) 1.02
Bunyaviridae: genome organization and replication strategies. Adv Virus Res (1991) 1.02
Na+ and K+ concentration and regulation of protein synthesis in L-A9 and Aedes albopictus cells infected with Marituba virus (Bunyaviridae). J Gen Virol (1989) 0.85
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci U S A (1996) 3.80
An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell (1984) 3.61
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J Gen Virol (1994) 2.69
Altruistic cell suicide and the specialized case of the virus-infected nervous system. Trends Neurosci (2000) 2.17
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology (2001) 2.16
High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Cell (1985) 2.14
Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins. Virology (1995) 2.13
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
[Guideline-conforming interventional treatment of acute ST-segment elevation myocardial infarction in rural areas using network collaboration]. Dtsch Med Wochenschr (2004) 2.11
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system. Virology (2001) 2.02
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet (2000) 2.00
RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment. J Virol (2000) 1.96
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood (1994) 1.95
The S RNA genome segments of Batai, Cache Valley, Guaroa, Kairi, Lumbo, Main Drain and Northway bunyaviruses: sequence determination and analysis. J Gen Virol (1994) 1.84
Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus. J Virol (1993) 1.82
Synthesis of bunyavirus-specific proteins in a continuous cell line (XTC-2) derived from Xenopus laevis. J Gen Virol (1985) 1.68
Simian virus 40 enhancer increases RNA polymerase density within the linked gene. Nature (1985) 1.66
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill (2013) 1.55
Enhancer activity correlates with the oncogenic potential of avian retroviruses. EMBO J (1985) 1.52
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. Eur J Neurol (2012) 1.51
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol (1995) 1.50
Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J (1986) 1.48
Virus replication in engineered human cells that do not respond to interferons. J Virol (2003) 1.44
Nucleotide sequence of the influenza A/duck/Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 overlapping gene structure in a divergent influenza virus RNA segment. Virology (1981) 1.44
RAPPER: the radiogenomics of radiation toxicity. Clin Oncol (R Coll Radiol) (2013) 1.42
[Magnetic resonance imaging of tibial periostitis]. J Radiol (1998) 1.38
Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J Gen Virol (1994) 1.35
Nucleotide sequence of the Bunyamwera virus M RNA segment: conservation of structural features in the Bunyavirus glycoprotein gene product. Virology (1986) 1.35
Transfer RNAs of potato (Solanum tuberosum) mitochondria have different genetic origins. Nucleic Acids Res (1990) 1.33
Mechanism of chaperonin action: GroES binding and release can drive GroEL-mediated protein folding in the absence of ATP hydrolysis. EMBO J (1996) 1.32
[A case of Goldenhar syndrome: acute vitamin A intoxication in the mother during pregnancy]. J Genet Hum (1975) 1.31
Non-viral sequences at the 5' ends of Dugbe nairovirus S mRNAs. J Gen Virol (1993) 1.30
Mutagenesis of the L protein encoded by Bunyamwera virus and production of monospecific antibodies. J Gen Virol (1992) 1.29
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest (1993) 1.27
Identification of 21r and 22r chromosomes by quinacrine fluorescence. Clin Genet (1972) 1.25
Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler (2004) 1.24
Redundancy of information in enhancers as a principle of mammalian transcription control. J Mol Biol (1988) 1.23
The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun (1997) 1.23
bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death. J Virol (1997) 1.23
Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.19
Genome subunit reassortment among Bunyaviruses analysed by dot hybridization using molecularly cloned complementary DNA probes. Virology (1984) 1.16
Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell (1983) 1.16
Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assist. Br J Anaesth (2005) 1.14
Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm. Virology (1993) 1.14
Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol (2000) 1.13
A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther (1999) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett (1996) 1.11
A perspective on the role of cromolyn sodium as an antiasthmatic agent. Chest (1971) 1.10
Persistent infection of Aedes albopictus C6/36 cells by Bunyamwera virus. Virology (1986) 1.10
Semliki Forest virus strongly reduces mosquito host defence signaling. Insect Mol Biol (2008) 1.09
The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci (1981) 1.09
Identification of nonstructural proteins encoded by viruses of the Bunyamwera serogroup (family Bunyaviridae). Virology (1985) 1.09
Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J Gen Virol (1996) 1.09
Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. J Neurovirol (1997) 1.09
Role of the NSs protein in the zoonotic capacity of Orthobunyaviruses. Zoonoses Public Health (2009) 1.06
Translation efficiencies of the 5' untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system. J Gen Virol (1998) 1.04
Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans. Experientia (1974) 1.04
The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397). Clin Oncol (R Coll Radiol) (2011) 1.04
Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol (2007) 1.03
The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses. Virus Res (1997) 1.03
Murine gammaherpesvirus-68 infection of and persistence in the central nervous system. J Gen Virol (2000) 1.02
The genomics revolution and radiotherapy. Clin Oncol (R Coll Radiol) (2007) 1.02
Virus infection induces neuronal apoptosis: A comparison with trophic factor withdrawal. Cell Death Differ (1998) 1.02
CDI Blood Parameter Monitoring System 500--a new tool for the clinical perfusionist. J Extra Corpor Technol (2000) 1.01
Duplication 11 (q21 to 23 leads to qter) syndrome. Birth Defects Orig Artic Ser (1977) 1.01
Expression of functional Bunyamwera virus L protein by recombinant vaccinia viruses. J Virol (1991) 1.00
Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol (2001) 1.00
A transcription enhancer in the Herpesvirus saimiri genome. EMBO J (1985) 0.99
Oligonucleotide microarray analysis of human lens epithelial cells: TGFbeta regulated gene expression. Mol Vis (2007) 0.99
[Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases]. Anaesthesist (2004) 0.98
Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol (1997) 0.97
Complete coding sequence of hepatitis C virus genotype 6a. Biochem Biophys Res Commun (1997) 0.97
Patient restraint and safety vests: minimizing the hazards. Dimens Health Serv (1981) 0.97
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology (1995) 0.97
CT and MR imaging in neuro-Behçet disease. J Comput Assist Tomogr (1986) 0.96
Radiosensitivity, radiogenomics and RAPPER. Clin Oncol (R Coll Radiol) (2006) 0.96
Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice. J Gen Virol (1987) 0.95
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J Neuroimmunol (2002) 0.95
Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity. Neuroscience (1998) 0.95
An ultrasonographic study of the organisation of sucking and swallowing by newborn infants. Dev Med Child Neurol (1986) 0.95
Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. Eur J Immunol (1993) 0.95
Characterization of Bunyamwera virus defective interfering particles. J Gen Virol (1992) 0.95
Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells. Brain (1994) 0.94
RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue. Neuropathol Appl Neurobiol (2011) 0.94
Enhanced influenza surveillance on Réunion Island (southern hemisphere) in the context of the emergence of influenza A(H1N1)v. Euro Surveill (2009) 0.94
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport (2000) 0.93
[EEG changes during sedation with gamma-hydroxybutyric acid]. Anaesthesist (1995) 0.93
Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS. Clin Exp Immunol (1983) 0.93
Enzymatic test for the detection of a riboflavin deficiency. NADPH-dependent glutathione reductase of red blood cells and its activation by FAD in vitro. Experientia (1968) 0.93
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol (2008) 0.93
Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol (2001) 0.93
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler (2012) 0.92